MedTrace Logo

Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome

NCT01788215 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-01-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to study the effect of a commonly used antibiotic, doxycycline, on the production of ovarian hormones and menstrual cycles in women with Polycystic Ovarian Syndrome (PCOS).

Conditions

  • Polycystic Ovarian Syndrome (PCOS)
  • Irregular Menstrual Cycles
  • Androgen Excess

Interventions

DRUG

doxycycline

200mg/day in divided doses of 100mg twice daily

OTHER

Sugar Pill

1 pill twice a day

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Kathleen M Hoeger, MD, MPH · University of Rochester

  • Stephen Hammes, MD · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01788215 on ClinicalTrials.gov